Publications by authors named "Mohd W Nasser"

44Publications

Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach.

Front Oncol 2020 22;10:593. Epub 2020 Apr 22.

Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2020.00593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188953PMC
April 2020

Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.

Biochim Biophys Acta Rev Cancer 2020 04 25;1873(2):188359. Epub 2020 Mar 25.

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA; Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbcan.2020.188359DOI Listing
April 2020

microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.

Mol Cancer 2020 02 15;19(1):29. Epub 2020 Feb 15.

Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-020-1140-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023699PMC
February 2020

A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study.

Cancer Treat Res Commun 2020 7;22:100162. Epub 2019 Oct 7.

Department of Medicine, VA Nebraska Western Iowa Health Care System, Omaha, NE, United States; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, United States; Early Phase Therapeutic Clinical Trials Unit, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctarc.2019.100162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315624PMC
October 2019

TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer.

Oncotarget 2018 Sep 27;9(71):33459-33470. Epub 2016 May 27.

Department of Pathology, Wexner Medical Center, Ohio State University (OSU), Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/9663
Publisher Site
http://dx.doi.org/10.18632/oncotarget.9663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173360PMC
September 2018

Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.

Oncotarget 2017 May;8(18):29668-29678

Department of Pathology and The Comprehensive Cancer Center, The Ohio State University, Wexner Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444694PMC
May 2017

RAGE: A novel target for breast cancer growth and metastasis.

Oncoscience 2016 3;3(2):52-3. Epub 2016 Mar 3.

Department of Pathology, The Ohio State University, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789569PMC
http://dx.doi.org/10.18632/oncoscience.294DOI Listing
March 2016

Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis.

Mol Oncol 2016 Feb 28;10(2):272-81. Epub 2015 Oct 28.

Department of Pathology, The Ohio State University Wexner Medical Center, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2015.10.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739522PMC
February 2016

Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway.

Mol Carcinog 2016 12 6;55(12):2063-2076. Epub 2016 Jan 6.

Department of Pathology, The Ohio State University, Columbus, Ohio.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22451DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063844PMC
December 2016

Erratum to: miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.

Mol Cancer 2015 Nov 16;14(1):195. Epub 2015 Nov 16.

Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460 W 12th Ave, Columbus, 43210, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-015-0451-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4647705PMC
November 2015

Non-contact method for directing electrotaxis.

Sci Rep 2015 Jun 9;5:11005. Epub 2015 Jun 9.

Department of Mechanical &Aerospace Engineering, The Ohio State University, Columbus, Ohio, U.S.A.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep11005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460731PMC
June 2015

Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.

Cancer Lett 2015 Aug 8;365(1):11-22. Epub 2015 May 8.

Department of Pathology, Comprehensive Cancer Center, The Ohio State Medical Center, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2015.05.002DOI Listing
August 2015

Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.

Mol Oncol 2015 Apr 19;9(4):906-19. Epub 2015 Jan 19.

Department of Pathology, The Ohio State University, Wexner Medical Center, 43210, USA; The Comprehensive Cancer Center, The Ohio State University, Wexner Medical Center, 43210, USA. Electronic address:

View Article

Download full-text PDF

Source
https://www.alchimiaweb.com/blogfr/wp-content/uploads/2015/0
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S157478911400295
Publisher Site
http://dx.doi.org/10.1016/j.molonc.2014.12.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387115PMC
April 2015

miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.

Mol Cancer 2015 Jan 27;14:11. Epub 2015 Jan 27.

Department of Pathology, The Ohio State University Wexner Medical Center, 840 BRT, 460W 12th Ave, Columbus, OH, 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-014-0275-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314775PMC
January 2015

CXCR3 deficiency enhances tumor progression by promoting macrophage M2 polarization in a murine breast cancer model.

Immunology 2014 Sep;143(1):109-19

Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA; Department of Oral Biology, The Ohio State University College of Dentistry, Columbus, OH, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imm.12293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137960PMC
September 2014

Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.

J Biol Chem 2011 Dec 20;286(52):44845-54. Epub 2011 Oct 20.

Department of Pathology, The Ohio State University Medical and Comprehensive Cancer Center, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M111.225466DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248020PMC
December 2011

Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.

PLoS One 2011 7;6(9):e23901. Epub 2011 Sep 7.

Department of Pathology and Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0023901PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168464PMC
February 2012

Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.

Cancer Prev Res (Phila) 2011 Jan 19;4(1):65-75. Epub 2010 Nov 19.

Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://cancerpreventionresearch.aacrjournals.org/cgi/doi/10.
Publisher Site
http://dx.doi.org/10.1158/1940-6207.CAPR-10-0181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486PMC
January 2011

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

J Biol Chem 2009 Nov 2;284(46):32015-27. Epub 2009 Sep 2.

Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M109.016774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797273PMC
November 2009

Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.

J Immunol 2009 Sep 10;183(5):3425-32. Epub 2009 Aug 10.

Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, NC 27707, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0900305DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860795PMC
September 2009

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis.

Cancer Res 2008 Jul;68(13):5049-58

Department of Molecular and Cellular Biochemistry, College of Pharmacy, and Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-07-6655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562630PMC
July 2008

Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer.

J Immunol 2008 Apr;180(8):5699-706

Julius L. Chambers Biomedical/Biotechnology Research Institute, Department of Biology, North Carolina Central University, Durham, NC 27707, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.8.5699DOI Listing
April 2008

CXCR1 and CXCR2 activation and regulation. Role of aspartate 199 of the second extracellular loop of CXCR2 in CXCL8-mediated rapid receptor internalization.

J Biol Chem 2007 Mar 4;282(9):6906-15. Epub 2007 Jan 4.

Julius L. Chambers Biomedical/Biotechnology Research Institute and the Department of Biology, North Carolina Central University, Durham, North Carolina 27707, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M610289200DOI Listing
March 2007

Cross-desensitization among CXCR1, CXCR2, and CCR5: role of protein kinase C-epsilon.

J Immunol 2005 Jun;174(11):6927-33

Julius L. Chambers Biomedical/Biotechnology Research Institute, North Carolina Central University, Durham, 27707, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.174.11.6927DOI Listing
June 2005